drugset / Trial / NCT07629778
HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a randomized, double-blind, placebo-controlled, multicenter Phase Ib/II clinical study designed to evaluate the efficacy, safety, and PK characteristics of HL-300 ointment with different concentration regimens for mild-to-moderate AD.
Timeline
- Start
- 2026-05-26
- Primary completion
- 2027-06-30
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HL-300 | Unknown | 0.25 % | — |
| Subject | HL-300 | Unknown | 0.5 % | — |
| Subject | HL-300 | Unknown | 1 % | — |